Intermediate and long term results of holmium laser enucleation of the prostate(HoLEP)for benign prostatic hyperplasia(BPH)

Bibliographic Information

Other Title
  • ホルミウムレーザー前立腺核出術の中・長期成績
  • ホルミウムレーザー ゼンリツセンカクシュツジュツ ノ ナカ ・ チョウキ セイセキ

Search this article

Abstract

  The present study was conducted to examine the intermediate and long term effects of holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia. 213 patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia underwent holmium laser enucleation of the prostate at our hospital. A total of 63, 44 and 29 patients were followed up for 36, 48 and 60 months, respectively. We evaluated the perioperative parameters, functional outcome(prostate volume, International Prostate Symptom Score, Quality of life score, maximum flow rate, average flowrate and post-void residual), and adverse events up to 36, 48 and 60 months post-operatively. The mean age of the patients was 71.6 years. The mean prostate volume was 65.1 ml. The mean weight of the enucleated tissue was 36.8 grams. The mean catheterization time was 2.4 days. All parameters improved significantly at each time point. The effect of holmium laser enucleation of the prostate therefore successfully continued for the intermediate and long term periods(36, 48 and 60 months).

Journal

Citations (2)*help

See more

References(14)*help

See more

Details 詳細情報について

Report a problem

Back to top